Fracking Firms: Victims of Their Own Success

Related Link: 

The fracking surge in Pennsylvania’s Marcellus Shale has caused gas prices to crater, forcing drillers to re-evaluate operations.

Luxottica Names P&G veteran as Co-CEO

Related Link: 

Luxottica named a P&G veteran as a co-CEO on Wednesday, seeking to put an end to a month of turmoil caused by the return of founder Leonardo Del Vecchio to active management of the world’s largest eyewear group.

Boeing Posts Strong Results

Related Link: 

Boeing Co. said its quarterly profit rose 18% and raised its 2014 guidance, but it also indicated costs for its flagship 787 Dreamliner program aren’t coming down as quickly as hoped.

GlaxoSmithKline Unveils Cost-Saving Plan

Related Link: 

GlaxoSmithKline announced new cost savings, plans to explore a partial listing of its ViiV Healthcare business and better-than-expected earnings.

Total Names Patrick Pouyanné CEO

Related Link: 

Total named refining and chemicals head Patrick Pouyanné as its new chief executive, after the death of Christophe de Margerie in a Moscow plane crash.

Google Japan Case Raises Privacy Issues

Related Link: 

A Japanese man who won a court order requiring Google to remove certain search results has asked the court to fine the company, saying it failed to fully remove results that could injure his reputation.

Interpublic Earnings Nearly Double

Related Link: 

Interpublic Group said its third-quarter earnings nearly doubled as revenue grew in both the domestic and international markets

Ex-Im Bank's Uncertain Future Worries Small Firms

Related Link: 

A decision by Congress to extend the Export-Import Bank only temporarily is raising concern among business owners who say they rely on the credit agency to lower the risks of exporting.

AT&T Lowers Revenue Outlook

Related Link: 

AT&T lowered its revenue outlook for the year, pointing to fewer-than-expected sign-ups for its no-contract Next wireless plans that require customers to pay full price for their smartphones.

Abbott Sales Rise, Mylan Deal Tweaked

Related Link: 

Abbott tweaked the terms of its agreement to sell a portion of its generic-drugs business to Mylan for $5.3 billion, signaling the deal will be completed despite new Treasury department rules.

Syndicate content